Linked Life Data

2686485

Source:http://linkedlifedata.com/resource/pubmed/id/2686485

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2686485rdf:typepubmed:Citationlld:pubmed
pubmed-article:2686485lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0238767lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C1522318lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0282636lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0022616lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0037533lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0542331lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C1442858lld:lifeskim
pubmed-article:2686485lifeskim:mentionsumls-concept:C0442121lld:lifeskim
pubmed-article:2686485pubmed:issue10lld:pubmed
pubmed-article:2686485pubmed:dateCreated1989-12-22lld:pubmed
pubmed-article:2686485pubmed:abstractTextTwenty patients requiring management of postoperative arterial hypertension following coronary artery bypass grafting (CABG) were randomly treated with either ketanserin (n = 10) or sodium nitroprusside (SNP) (n = 10). After surgery all patients were mechanically ventilated in the intensive care unit (F1O2:0.5; PEEP: +5 cm H2O). During the therapy with either drug F1O2 was adjusted to achieve normal blood oxygen tensions (F1O2 always greater than 0.3). Samples of arterial and mixed-venous blood were obtained simultaneously before administration of either drug and at each time point. Data acquisition followed over 12 h. Both drugs led to a significant decrease in arterial blood pressure, although 2 patients had to be withdrawn from the ketanserin group because there was no adequate decrease in systolic arterial pressure. A significant increase in heart rate was noted only in patients receiving SNP. In the SNP-treated patients F1O2 had to be increased because of a marked decrease in paO2, resulting in a significant increase in alveolar-arterial oxygen difference (A-aDO2). In 3 patients SNP had to be stopped because of an increase in intrapulmonary shunt (Qsp/Qt) more than 30%. No significant changes in Qsp/Qt, A-aDO2, or paO2 were seen in the ketanserin-treated patients.lld:pubmed
pubmed-article:2686485pubmed:languagegerlld:pubmed
pubmed-article:2686485pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2686485pubmed:citationSubsetIMlld:pubmed
pubmed-article:2686485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2686485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2686485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2686485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2686485pubmed:statusMEDLINElld:pubmed
pubmed-article:2686485pubmed:monthOctlld:pubmed
pubmed-article:2686485pubmed:issn0003-2417lld:pubmed
pubmed-article:2686485pubmed:authorpubmed-author:MüllerEElld:pubmed
pubmed-article:2686485pubmed:authorpubmed-author:LauwersPPlld:pubmed
pubmed-article:2686485pubmed:authorpubmed-author:Van AkenHHlld:pubmed
pubmed-article:2686485pubmed:authorpubmed-author:MöllhoffTTlld:pubmed
pubmed-article:2686485pubmed:authorpubmed-author:MulierJ PJPlld:pubmed
pubmed-article:2686485pubmed:issnTypePrintlld:pubmed
pubmed-article:2686485pubmed:volume38lld:pubmed
pubmed-article:2686485pubmed:ownerNLMlld:pubmed
pubmed-article:2686485pubmed:authorsCompleteYlld:pubmed
pubmed-article:2686485pubmed:pagination519-24lld:pubmed
pubmed-article:2686485pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:meshHeadingpubmed-meshheading:2686485-...lld:pubmed
pubmed-article:2686485pubmed:year1989lld:pubmed
pubmed-article:2686485pubmed:articleTitle[Ketanserin versus sodium nitroprusside in the treatment of hypertension following coronary surgery. Effect on intrapulmonary right and left shunt and arterial oxygenation].lld:pubmed
pubmed-article:2686485pubmed:affiliationDepartment of Anesthesiologie, Katholieke Universiteit Leuven, Belgien.lld:pubmed
pubmed-article:2686485pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2686485pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2686485pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2686485pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:2686485pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2686485lld:pubmed